M. Alberry
Qatar Airways
24 Papers
112 Citations
M. Alberry is an academic researcher from Qatar Airways. The author has contributed to research in topics: Cell-free fetal DNA & Pregnancy. The author has an hindex of 8, co-authored 23 publications. Previous affiliations of M. Alberry include St. Michael's GAA, Sligo & Bristol Royal Hospital for Children.
Chat about Author
Papers
The SAFE project: towards non-invasive prenatal diagnosis.
Deborah G. Maddocks,M. Alberry,G. Attilakos,Tracey E. Madgett,Kin Choi,Peter W. Soothill,Neil D. Avent +6 more
TL;DR: The SAFE project was set up to implement routine, cost-effective NIPD and neonatal screening through the creation of long-term partnerships within and beyond the European Community and has played a major role in the standardization of non-invasive RHD genotyping.
49
Non invasive prenatal testing (NIPT) for common aneuploidies and beyond.
TL;DR: Non-invasive prenatal testing (NIPT) as mentioned in this paper is a widely used method for prenatal diagnosis that is based on the detection and analysis of cell free fetal DNA (cffDNA) obtained from a maternal peripheral blood sample.
43
Exploring ChatGPT’s Potential in Facilitating Adaptation of Clinical Guidelines: A Case Study of Diabetic Ketoacidosis Guidelines
TL;DR: In this article , the authors evaluated the efficacy of ChatGPT, an advanced natural language processing model, in adapting and synthesizing clinical guidelines for diabetic ketoacidosis (DKA) by comparing and contrasting different guideline sources.
Management of fetal malposition in the second stage of labor: a propensity score analysis.
TL;DR: Rotational instrumental delivery is often regarded as unsafe, but it is found that neonatal outcomes are no worse once selection bias is accounted for, and that the likelihood of severe obstetric hemorrhage is reduced.
27
Intraumbilical injection of three different uterotonics in the management of retained placenta
TL;DR: The aim of this work was to compare the effect of intraumbilical injection of three different uterotonic solutions in the management of retained placenta.
20